SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-286232
Filing Date
2020-11-05
Accepted
2020-11-05 07:31:01
Documents
13
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d72182d8k.htm   iXBRL 8-K 25587
2 EX-99.1 d72182dex991.htm EX-99.1 75314
  Complete submission text file 0001193125-20-286232.txt   237817

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arvn-20201105.xsd EX-101.SCH 3067
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20201105_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20201105_pre.xml EX-101.PRE 11858
6 EXTRACTED XBRL INSTANCE DOCUMENT d72182d8k_htm.xml XML 3475
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 201288691
SIC: 2834 Pharmaceutical Preparations